Izindaba

I-NEW YORK, Juni 23, 2022 (I-GLOBE NEWSWIRE) - I-Reportlinker.com imemezela ukukhishwa kombiko othi "I-Global Intravenous Therapy and Intravenous Access Market size, Share and Industry Trends Analysis Report, Outlook and Forecast by End User, Application, Type, Region , 2022-2028″ - https://www.reportlinker.com/p06283441/?utm_source=GNW Indlela eshesha kakhulu yokufaka uketshezi ezingxenyeni ezihlukene zomzimba iwukwelashwa nge-IV.Isifo senhliziyo, unhlangothi, kanye nobuthi konke kwelashwa ngalo muthi.Kulokhu, isiguli kufanele selashwe ngomuthi ngokushesha ngangokunokwenzeka, ngaleyo ndlela sinikeze umuthi imishanguzo yokwelapha i-immune, i-globulin antifungars, i-antifungal edambisa izinhlungu. zokwelapha, kanye nemithi yomfutho wegazi inikezwa ngomthambo.Ukwelashwa nge-Intravenous (IV) kuyindlela yokulethwa kwemithi noketshezi emzimbeni ngomthambo.Imithi equkethe amavithamini namaminerali inikezwa ngokuvuza ngomthambo noma ngomjovo womjovo, okuvumela ukwelashwa ukuthi kugeleze ngokushesha egazini.Ngokwe-Scope, ukuphathwa kwe-IV kulapho isiguli singafaka khona ishubhu ngokuqondile. yomuthi noma ukuntuleka kokudla okunomsoco.Ukwelashwa kwe-IV kuyindlela evamile yokuhlinzeka ngamanzi, izidakamizwa, i-chemotherapy, kanye nokumpontshelwa igazi ezigulini eziphelelwe amanzi.Ngesikhathi sokuphatha kwe-IV, imishini ehlukahlukene ye-IV efana ne-IV catheter, amaphampu okufakwayo, amadivaysi e-immobilization, kanye namakhithi okuphatha asetshenziswa.Ukuphathwa kokwelashwa kwe-IV kuyashesha, kulula ukukulandela, futhi akunayo impendulo ye-immune ye-gastrointestinal kanye nemiphumela yokwelapha engapheli. iphampu yokufaka elawula inani lamakhemikhali okumele ahlinzekwe emzimbeni futhi angaqashelwa kalula.Imakethe yomhlaba wonke yokwelapha nge-intravenous kanye nemishini yokufinyelela ngomthambo kulindeleke ukuthi ikhule phakathi nesikhathi sokubikezela.Ukusabalala kwesifo sikashukela, ukukhuphuka kwezigameko zezingozi zomgwaqo, nokwanda kwezinqubo zokuhlinza kulindeleke ukuthi kuqhubekisele phambili imboni.Umkhakha okhulayo wesidingo sezidakamizwa nawo uqhutshwa yisidingo esinamandla sezidakamizwa. ukulethwa.I-COVID-19 Impact COVID-19 inomthelela omuhle jikelele emakethe yokwelapha ye-IV. Ezigulini ezine-COVID-19 ehlobene ne-acute breathing distress syndrome, kulawulwa i-IV therapy (ARDS). Umuthi ngoNovemba 11, 2021 ngenxa yokuthi Amandla okushintsha amasosha omzimba amaningi ngesikhathi esisodwa.Ngakho-ke, ngokwanda kwenani leziguli ezine-ARDS ehlobene ne-COVID-19, isidingo sokwelashwa kwe-IV kanye nemikhiqizo yokufinyelela emthanjeni siyakhula.Izici Zokukhula Kwemakethe Ukwandisa Ukusebenza kanye Nokukhula Kwesibalo Sabantu Abagulayo Ukukhula kwezifo ezingamahlalakhona kuye kwanda ukwanda kwezifo ezingapheli ze-Chr. izifo ezinjengomdlavuza, ukwehluleka kwezinso nesifo senhliziyo, kanye nezindlela ezihlukahlukene zokuphila ezinjengomfutho wegazi ophakeme, isifo sikashukela, ukukhuluphala ngokweqile nokucindezeleka, zidinga ukunakekelwa okukhulu ngesikhathi sokuhlala esibhedlela. Kule minyaka embalwa ezayo, ukwanda komthwalo wezifo ezingelapheki njengesifo senhliziyo nemithambo yegazi, umdlavuza, unhlangothi, nesifo sikashukela, kuhambisana nokuguga kwabantu, kuzokwandisa isidingo sokwelashwa nge-intravenous, kanye nezinsiza zokuphepha ze-Intravenological and the central amaphampu okufakwa ithiphu aphakathi kwezinsiza zobuchwepheshe ezifaka isandla ekusetshenzisweni kwe-intravenous therapy (IVT) ephephile, nesezingeni eliphezulu. Njengoba ubuchwepheshe bezempilo buyisiyalo esiyinkimbinkimbi, esicatshangelwa futhi sixoxisana nsuku zonke ngochwepheshe bezempilo ababambe iqhaza ekunakekelweni kweziguli egunjini labagula kakhulu, umkhakha wokunakekelwa ube nezinguquko ezinkulu ngenxa yokufakwa kobuchwepheshe obusha, futhi izinsiza zokwelapha ezisezingeni eliphezulu ziwukuthola usizo oluphezulu lwephampu yobuchwepheshe. (IVT) ukuzijwayeza.Izingqinamba Zemakethe Ukukhiqizwa kwephampu kudinga imithetho eqinile kanye nokukhathazeka mayelana nezinkinga Inqubo yokunikeza amalayisense amaphrojekthi amasha iqhutshwa ngokuphathelene nokukhiqizwa kwepompo kanye nokuhlanganisa.Ukwengeza, ukukhuphuka komkhiqizo okukhumbulayo ngenxa yokukhubazeka kokukhiqiza kuzobambezela ukwamukelwa kwalezi zindlela zokwelapha.Ngokwesibonelo, iFresenius Kabi ku-Augustrum Infusion ye-August Pump Descargant kanye ne-Augustrum Infusion Pump Descargant. 2019 ngenxa yezinkinga zokuxwayisa ngokufakwa, okubaluleke kakhulu i-Keep Vein Open (KVO) nezinye iziphazamisi zesofthiwe.Isithiyo esikhulu ekukhuleni kwemboni izinkinga ezihambisana nokusetshenziswa kwezindlela ze-IV kanye nemikhiqizo yokufakwa kwe-IV. I-End User Outlook Ngokusekelwe kumsebenzisi wokugcina, imakethe ihlukaniswe ngezibhedlela, izikhungo zokuhlinza ama-ambulensi, kanye nesabelomali esikhulu sokwelashwa ezibhedlela. kanye nemakethe yokufinyelela kwe-venous ngo-2021.Lokhu kungenxa yokwanda kwenani lokuhlinzwa okwenziwa uma kuqhathaniswa nezikhungo zokuhlinza iziguli kanye nemitholampilo.Ngaphezu kwalokho, ukukhula kwengxenye kwabangelwa ukwanda kokwelashwa kwe-intravenous ezibhedlela, okuhlanganisa i-intravenous antibiotic therapy, izidakamizwa zeziguli ze-comatose, izidakamizwa ezingeke zithathwe, isampula ye-radiology, i-heacan therapy, i-heacan therapy, i-heacan, i-heacan, i-heacan, i-heacan, i-heacan, isampula yegazi, i-heacan therapy. kanye nokumpontshelwa igazi .Imakethe yokwelashwa kwe-IV kanye namadivayisi okufinyelela e-venous iyakhula ngenxa yentuthuko yezobuchwepheshe kanye nokutshalwa kwezimali kwesibhedlela.I-Application Outlook Ngokusekelwe kwesicelo, imakethe ihlukaniswe yaba ukuphathwa kwezidakamizwa, imikhiqizo esekelwe egazini, izixazululo zokudla okunomsoco kanye ne-buffer, kanye nemikhumbi yokwandisa.Ngo-2021, ingxenye ye-Volume Expander izothola isabelo esibalulekile sokwelashwa (IV) Imakethe.Uketshezi olufakwa emthanjeni lungase lube wusizo enanini elincane labasubathi abangezwani noketshezi; nokho, lokhu kufanele kubekelwe abasubathi bezinga eliphezulu abanomlando wezimpawu eziqinile ngaphansi kokuqashwa kahle.Abanye abasubathi bangase bazuze ngokusebenzisa i-expander.Uketshezi olufakwa emthanjeni kanye nezibophelelo ze-plasma akuvunyelwe emiqhudelwaneni elawulwa yi-WADA.Kuhlobo olungcono kakhulu lwe-Outlook IV inketho yokwelapha. ohlotsheni, imakethe ihlukaniswe yaba ama-catheter afakwa emthanjeni, amaphampu okufakwayo, izinaliti ze-hypodermic, amachweba afakelwayo, nokunye. Ngo-2021, ingxenye ye-intravenous catheter izothatha isabelo esikhulu semali engenayo emakethe ye-intravenous (IV) yokwelashwa kanye ne-venous access market. ezingxenyeni ezihlukahlukene zomzimba.Amapayipi afakwa emthanjeni amashubhu amancane afakwe emgodini womzimba noma ilume.I-catheter emithanjeni iyi-catheter efakwa emthanjeni esetshenziselwa ukuletha izidakamizwa, uketshezi, noma ezinye izindlela zokwelapha ngokuqondile emgudwini wegazi.Imvamisa ifakwa emthanjeni osengalweni, nakuba ingaphinde ifakwe entanyeni, esifubeni, noma emithonjeni ehlukahlukene ye-grooves. I-Regional Outlook Ngokusekelwe esifundeni, imakethe ihlukaniswe eNyakatho Melika, eYurophu, e-Asia Pacific naseLatin America, Middle East nase-Afrika.Ngo-2021, iNyakatho Melika iyisifunda esihamba phambili emakethe ye-intravenous (IV) therapy kanye ne-venous access market ngokubamba isabelo semakethe esiphezulu kakhulu semali engenayo. ekuthuthukiseni izikhungo zezokwelapha ezingcono kanye nemisebenzi ye-R&D.Umbiko wocwaningo lwemakethe uhlanganisa ukuhlaziya ababambiqhaza ababalulekile bemakethe.Izinkampani ezinkulu ezivezwe embikweni zifaka phakathi i-B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter Smithy Démicy Inc. Amasu eMakethe yokwelapha kanye ne-Intravenous Access Market Mashi 2022: I-Fresenius Kabi isayine isivumelwano sokuthola i-Fresenius Kabi, inkampani yezempilo yomhlaba wonke. U-Baxter wenza ubambiswano nomhlinzeki wezobuchwepheshe bezokwelapha wase-US u-Hillrom. Ngalokhu kubambisana, lezi zinkampani ezimbili zihlose ukuhlanganisa amabhizinisi amabili amakhulu ezobuchwepheshe ukuze kuzuzwe umbono ofanayo wokuguqula ukunakekelwa kwezempilo emhlabeni wonke kanye nokuthuthukisa ukunakekelwa kweziguli.May 2021: Smiths Medical yenza ubudlelwano nenkampani yobuchwepheshe bezokwelapha i-Ivenix. yakhelwe ukuguqula ukuphathwa kokuxuba nokuthuthukisa impilo yesiguli, kuyilapho ihlangabezana nezidingo zabahlinzeki bezempilo. Ngo-Ephreli 2021: I-B. Braun Medical yethula uhlelo olusha, i-Peripheral Advantage, ukuthuthukisa ulwazi lweziguli ngokwelashwa nge-peripheral intravenous. 2019: U-Baxter uthola imvume ye-US Food and Drug Administration (FDA) ye-Myxredlin. Ukugunyazwa kuvumela i-insulin esheshayo yokujova ngomthambo ezibhedlela nakwezinye izilungiselelo zokunakekela abaguli kakhulu futhi uneshelufu elibanzi lezinsuku ezingu-30 noma izinyanga ezingu-24 ekamelweni lokushisa uma lifakwe esiqandisini ephaketheni lokuqala ukuze kuqinisekiswe ukuvikeleka kokuthi I-Ambulance Center • Imibiko Yesicelo: Ukuphathwa Kwemithi • Imikhiqizo Yegazi • Izixazululo Zezakhi Nezivikeli • Imikhumbi Yokusabalalisa Ngohlobo • Ama-Catheter Angenamthambo • Amaphampu Okufakwayo • Izinaliti Ze-Hypodermic • Izimbobo Ezifakwayo • Okunye Nge-Geography • ENyakatho Melika o USo Canadao Mexico Yonke indawo yaseNyakatho Melika • I-Europe Germany o UKo France Russia I-Spain Italy o Yonke indawo yase-Europe • I-Asia Pacific China o I-Indiast Korea yase-Asia E-Asia yase-Brazil LAME I-Asia yase-Asia Pacific I-Nigeria LAMEA Rest Company Profile• B. Braun Melsungen AG • Medtronic PLC• Terumo Corporation• Fresenius SE & Co. KGaA• Cardinal Health, Inc.• Pfizer, Inc.• Teleflex, Inc.• Baxter International, Inc.• Smiths Group PLC• AngioDynamics, Inc. Uniquetive Offerings Exhable-Details Imodeli Iyatholakala • Intengo Engcono Kakhulu Iqinisekisiwe • Ucwaningo Oluqinisekisiwe Ngemva Kokuthengisa Lusekelwa 10% Ukwenza Ngokwezifiso Funda umbiko ogcwele mahhala: https://www .reportlinker.com/p06283441/?utm_source=GNWAbout ReportlinkerReportLinker iyinhlangano ewina umklomelo yocwaningo lwemakethe. Umhlanganisi wedatha owudingayo ungathola isisombululo sakamuva socwaningo lwemakethe. indawo eyodwa ___________________________________